TAK-901

未知生产厂商

TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.

技术标识符

化学式: C₂₈H₃₂N₄O₃S
CAS 编号: 934541-31-8
UNII ID: DM9UIR23R7

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Compounds for treatment of hepatitis b
CN 114555089 A申请人: SINGAPORE SCIENCE AND TECH RESEARCH BUREAU优先权: 2019
CN

药物